Current filters:

Start a new search
Add filters:

Use filters to refine the search results.

Results 1-10 of 48 (Search time: 0.005 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2015Toll-like receptor 4 signaling: a common biological mechanism of regimen-related toxicities an emerging hypothesis for neuropathy and gastrointestinal toxicityWardill, H.; Van Sebille, Y.; Mander, K.; Gibson, R.; Logan, R.; Bowen, J.; Sonis, S.
2007Irinotecan changes gene expression in the small intestine of the rat with breast cancerBowen, J.; Gibson, R.; Cummins, A.; Tyskin, A.; Keefe, D.
2005Cytotoxic chemotherapy upregulates pro-apoptotic Bax and Bak in the small intestine of rats and humansBowen, J.; Gibson, R.; Keefe, D.; Cummins, A.
2007Establishment of a Single-Dose Irinotecan Model of Gastrointestinal MucositisGibson, R.; Bowen, J.; Alvarez, E.; Finnie, J.; Keefe, D.
2005Relationship between dose of methotrexate, apoptosis, p53/p21 expression and intestinal crypt proliferation in the ratGibson, R.; Bowen, J.; Cummins, A.; Keefe, D.
2005Palifermin reduces diarrhea and increases survival following Irinotecan treatment in tumor-bearing DA ratsGibson, R.; Bowen, J.; Keefe, D.
2016Tight junction defects are seen in the buccal mucosa of patients receiving standard dose chemotherapy for cancerWardill, H.; Logan, R.; Bowen, J.; Van Sebille, Y.; Gibson, R.
2016Cytokine-mediated blood brain barrier disruption as a conduit for cancer/chemotherapy-associated neurotoxicity and cognitive dysfunctionWardill, H.; Mander, K.; Van Sebille, Y.; Gibson, R.; Logan, R.; Bowen, J.; Sonis, S.
2016A novel in vitro platform for the study of SN38-induced mucosal damage and the development of Toll-like receptor 4-targeted therapeutic optionsWardill, H.; Gibson, R.; Van Sebille, Y.; Secombe, K.; Logan, R.; Bowen, J.
2017Dacomitinib-induced diarrhoea is associated with altered gastrointestinal permeability and disruption in ileal histology in ratsVan Sebille, Y.; Gibson, R.; Wardill, H.; Secombe, K.; Ball, I.; Keefe, D.; Finnie, J.; Bowen, J.